- Report
- April 2023
- 129 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2023
- 220 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €3123EUR$3,250USD£2,681GBP
- Report
- September 2022
- 140 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- August 2020
- 80 Pages
Global
From €3123EUR$3,250USD£2,681GBP
- Report
- August 2023
- 74 Pages
Canada
From €3363EUR$3,500USD£2,887GBP
- Report
- August 2023
- 73 Pages
Israel
From €3363EUR$3,500USD£2,887GBP
- Report
- March 2022
- 142 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- June 2020
- 150 Pages
Asia Pacific
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- June 2020
- 160 Pages
Europe
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- April 2023
- 100 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- November 2020
- 101 Pages
Global
€21139EUR$22,000USD£18,146GBP
- Report
- June 2018
- 11 Pages
Global
From €9608EUR$10,000USD£8,248GBP
- Report
- June 2018
- 21 Pages
Global
From €9608EUR$10,000USD£8,248GBP
- Report
- June 2018
- 15 Pages
Global
From €9608EUR$10,000USD£8,248GBP
- Report
- June 2018
- 16 Pages
Global
From €9608EUR$10,000USD£8,248GBP
- Report
- June 2018
- 11 Pages
Global
From €9608EUR$10,000USD£8,248GBP
- Report
- June 2018
- 17 Pages
Global
From €9608EUR$10,000USD£8,248GBP
- Drug Pipelines
- October 2020
- 50 Pages
Global
From €3363EUR$3,500USD£2,887GBP
The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more